Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

GENT: Disclosure of large shareholding in Gentian Diagnotics ASA

Gentian Diagnostics
Gentian Diagnostics ASA - Disclosure of Large Shareholding
Oslo, Norway, March 3, 2025

Insr ASA and Norda ASA have today acquired in total 1,228,502 shares (614,251
shares each) in Gentian Diagnostics ASA at an average price of NOK 46.5 per
share. Insr ASA and Norda ASA will together with the Group of companies Kvantia
AS, Obligasjon 2 AS, Caaby AS, RWD AS and Victoria India Fund AS following the
share transactions hold in total 3,422,370 shares in Gentian Diagnostics ASA,
corresponding to approx. 22.2% of the total outstanding shares.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.